| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 133, 690-698, Copyright © 1993 by Endocrine Society
ARTICLES |
T Endo, RF Aten, F Wang and HR Behrman
Department of Obstetrics/Gynecology, Yale University School of Medicine, New Haven, Connecticut 06510-8063.
Structural luteolysis was found decades ago to be induced by PRL in the hypophysectomized rat, but the mechanisms of this process are unknown. To gain information on mechanisms of luteal involution, we developed an animal model that circumvented complex surgery and provided ample tissue for analyses. Gonadotropin-synchronized ovulation and luteinization were induced in immature rats, followed by treatment with ergot alkaloid and PRL. PRL-induced structural luteolysis, as shown by loss of luteal weight, protein, and DNA after pretreatment with ergot alkaloid, was evident after 36 h. Ascorbic acid depletion was rapid, severe, and lasting in luteal tissue during structural luteolysis, but lipid peroxidation or depletion of vitamin E was not evident. PRL treatment of animals with functional corpora lutea did not induce luteal involution. Significantly, after natural functional luteolysis occurred, PRL was highly effective in inducing structural luteolysis. Thus, either natural or ergot-induced functional luteolysis permitted the luteolytic expression of PRL. A greater depletion of protein than DNA was seen during PRL-induced structural luteolysis and was associated with a significant increase in neutral caseinase activity in luteal extracts. Caseinase activity was markedly reduced by calcium chelators and profoundly inhibited by the chelator orthophenanthroline; only slightly reduced activity was seen with serine, aspartate, or cysteine proteinase inhibitors. These findings implicate metalloproteinase (MMP) as the relevant caseinase that was increased during structural luteolysis. The major proteinase identified by zymography had apparent sizes of 72 and 66 kilodaltons (kDa), and slight but detectable activity was also seen at 92 and 84 kDa. Organomercurial treatment caused a major shift of the 72-kDa band to 66 kDa and the 92-kDa band to 84 kDa, confirming MMP-2 and MMP-9 by activation of latent activity of each MMP, respectively. Structural luteolysis caused a significant increase in the activated 66-kDa form and the latent 72-kDa form of MMP-2, which occurred before a loss of luteal weight or protein. As MMP-2 degrades collagen (type IV) in basement membranes, we conclude that an early event in PRL-induced structural luteolysis is the degradation of extracellular matrix. This conclusion is further emphasized by the marked and lasting depletion of ascorbic acid, a vitamin long known to serve an essential role in collagen synthesis.
This article has been cited by other articles:
![]() |
E.-S. Park, S. Choi, K. N. Muse, T. E. Curry Jr., and M. Jo Response Gene to Complement 32 Expression Is Induced by the Luteinizing Hormone (LH) Surge and Regulated by LH-Induced Mediators in the Rodent Ovary Endocrinology, June 1, 2008; 149(6): 3025 - 3036. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Myers, M. C. Lamont, S. van den Driesche, N. Mary, K. J. Thong, S. G. Hillier, and W. C. Duncan Role of Luteal Glucocorticoid Metabolism during Maternal Recognition of Pregnancy in Women Endocrinology, December 1, 2007; 148(12): 5769 - 5779. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Myers, E. Gay, A. S. McNeilly, H. M. Fraser, and W. C. Duncan In Vitro Evidence Suggests Activin-A May Promote Tissue Remodeling Associated with Human Luteolysis Endocrinology, August 1, 2007; 148(8): 3730 - 3739. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Stocco, C. Telleria, and G. Gibori The Molecular Control of Corpus Luteum Formation, Function, and Regression Endocr. Rev., February 1, 2007; 28(1): 117 - 149. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. McDonnel Smedts and T.E. Curry Jr. Expression of Basigin, an Inducer of Matrix Metalloproteinases, in the Rat Ovary Biol Reprod, July 1, 2005; 73(1): 80 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jo and T. E. Curry Jr Regulation of Matrix Metalloproteinase-19 Messenger RNA Expression in the Rat Ovary Biol Reprod, December 1, 2004; 71(6): 1796 - 1806. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Curry Jr. and K. G. Osteen The Matrix Metalloproteinase System: Changes, Regulation, and Impact throughout the Ovarian and Uterine Reproductive Cycle Endocr. Rev., August 1, 2003; 24(4): 428 - 465. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Pru, I. R. Hendry, J. S. Davis, and B. R. Rueda Soluble Fas Ligand Activates the Sphingomyelin Pathway and Induces Apoptosis in Luteal Steroidogenic Cells Independently of Stress-Activated p38MAPK Endocrinology, November 1, 2002; 143(11): 4350 - 4357. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.A. Young, J.D. Hennebold, and R.L. Stouffer Dynamic expression of mRNAs and proteins for matrix metalloproteinases and their tissue inhibitors in the primate corpus luteum during the menstrual cycle Mol. Hum. Reprod., September 1, 2002; 8(9): 833 - 840. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Cavicchio, J. K. Pru, B. S. Davis, J. S. Davis, B. R. Rueda, and D. H. Townson Secretion of Monocyte Chemoattractant Protein-1 by Endothelial Cells of the Bovine Corpus Luteum: Regulation by Cytokines But Not Prostaglandin F2{alpha} Endocrinology, September 1, 2002; 143(9): 3582 - 3589. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Manase, T. Endo, H. Henmi, Y. Kitajima, K. Yamazaki, A. Nishikawa, T. Mitaka, H. Sato, and R. Kudo The significance of membrane type 1 metalloproteinase in structural involution of human corpora lutea Mol. Hum. Reprod., August 1, 2002; 8(8): 742 - 749. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Ricke, G. W. Smith, E. W. McIntush, and M. F. Smith Analysis of Luteal Tissue Inhibitor of Metalloproteinase-1, -2, and -3 During Prostaglandin F2{alpha}-Induced Luteolysis Biol Reprod, May 1, 2002; 66(5): 1387 - 1394. [Abstract] [Full Text] |
||||
![]() |
T. A. Towle, P. C.W. Tsang, R. A. Milvae, M. K. Newbury, and J. A. McCracken Dynamic In Vivo Changes in Tissue Inhibitors of Metalloproteinases 1 and 2, and Matrix Metalloproteinases 2 and 9, During Prostaglandin F2{alpha}-Induced Luteolysis in Sheep Biol Reprod, May 1, 2002; 66(5): 1515 - 1521. [Abstract] [Full Text] |
||||
![]() |
W. A. Ricke, G. W. Smith, and M. F. Smith Matrix Metalloproteinase Expression and Activity Following Prostaglandin F2{alpha}-Induced Luteolysis Biol Reprod, March 1, 2002; 66(3): 685 - 691. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zetser, T. Kisliouk, E. Ivakin, and M. Lahav Dependence on Prolactin of the Luteolytic Effect of Prostaglandin F2{alpha} in Rat Luteal Cell Cultures Biol Reprod, October 1, 2001; 65(4): 1082 - 1091. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Curry Jr and K. G. Osteen Cyclic Changes in the Matrix Metalloproteinase System in the Ovary and Uterus Biol Reprod, May 1, 2001; 64(5): 1285 - 1296. [Abstract] [Full Text] |
||||
![]() |
K. K. Olson, L. E. Anderson, M. C. Wiltbank, and D. H. Townson Actions of Prostaglandin F2{{alpha}} and Prolactin on Intercellular Adhesion Molecule-1 Expression and Monocyte/Macrophage Accumulation in the Rat Corpus Luteum Biol Reprod, March 1, 2001; 64(3): 890 - 897. [Abstract] [Full Text] |
||||
![]() |
H. H. T. Endo, K. Nagasawa, T. Hayashi, M. Chida, N. Akutagawa, M. Iwasaki, Y. Kitajima, T. Kiya, A. Nishikawa, K. Manase, et al. Lysyl Oxidase and MMP-2 Expression in Dehydroepiandrosterone-Induced Polycystic Ovary in Rats Biol Reprod, January 1, 2001; 64(1): 157 - 162. [Abstract] [Full Text] |
||||
![]() |
J. M. Bowen and P. L. Keyes Repeated Exposure to Prolactin Is Required to Induce Luteal Regression in the Hypophysectomized Rat Biol Reprod, April 1, 2000; 63(4): 1179 - 1184. [Abstract] [Full Text] |
||||
![]() |
G. D. Niswender, J. L. Juengel, P. J. Silva, M. K. Rollyson, and E. W. McIntush Mechanisms Controlling the Function and Life Span of the Corpus Luteum Physiol Rev, January 1, 2000; 80(1): 1 - 29. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Liu, J. I. Olofsson, P. Wahlberg, and T. Ny Distinct Expression of Gelatinase A [Matrix Metalloproteinase (MMP)-2], Collagenase-3 (MMP-13), Membrane Type MMP 1 (MMP-14), and Tissue Inhibitor of MMPs Type 1 Mediated by Physiological Signals During Formation and Regression of the Rat Corpus Luteum Endocrinology, November 1, 1999; 140(11): 5330 - 5338. [Abstract] [Full Text] |
||||
![]() |
R. G. I. Cooke, W. B. Nothnick, C. Komar, P. Burns, and T. E. Curry Jr Collagenase and Gelatinase Messenger Ribonucleic Acid Expression and Activity During Follicular Development in the Rat Ovary Biol Reprod, November 1, 1999; 61(5): 1309 - 1316. [Abstract] [Full Text] |
||||
![]() |
T. G. Zreik, P. H. Kodaman, E. E. Jones, D. L. Olive, and H. Behrman Identification and characterization of an ascorbic acid transporter in human granulosa–lutein cells Mol. Hum. Reprod., April 1, 1999; 5(4): 299 - 302. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Aten, T. R. Kolodecik, M. J. Rossi, C. Debusscher, and H. R. Behrman Prostaglandin F2{alpha} Treatment In Vivo, but Not In Vitro, Stimulates Protein Kinase C-Activated Superoxide Production by Nonsteroidogenic Cells of the Rat Corpus Luteum Biol Reprod, November 1, 1998; 59(5): 1069 - 1076. [Abstract] [Full Text] |
||||
![]() |
W. C. Duncan, A. S. McNeilly, and P. J. Illingworth The Effect of Luteal "Rescue" on the Expression and Localization of Matrix Metalloproteinases and Their Tissue Inhibitors in the Human Corpus Luteum J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2470 - 2478. [Abstract] [Full Text] |
||||
![]() |
E. Bjurulf, O. Toffia, G. Selstam, and J. I. Olofsson Luteolysis Induced by a Prostaglandin F2{alpha} Analogue Occurs Independently of Prolactin in the Rat Biol Reprod, July 1, 1998; 59(1): 17 - 21. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |